Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs VCIT: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to VCIT's −1.8%, and VCIT charges 0.03% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and VCIT

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $66.6bn on Sep 30, 2026 for Vanguard Intermediate-Term Corporate Bond ETF.

At a glance
+37.5%
IBB total return, 1 year
−1.8%
VCIT total return, 1 year
0.44%
IBB expense ratio
0.03%
VCIT expense ratio

Pair scorecard

VCIT costs 0.41 points a year less; their one-year returns differ by 39.3 points; VCIT is 5.9 times larger.

IBB vs VCIT: Differences, Returns & Fees
MeasureIBBVCIT
Return
Total return, 1 year+37.5%−1.8%
Drawdown
Below its high3.2%, high on Feb 27, 2026
Benchmark
What it tracksBiotechBloomberg U.S. 5-10 Year Corporate Bond Index
Cost and size
Expense ratio0.44%0.03%
Net assets, as of Sep 30, 2026$11.2bn$66.6bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and VCIT hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB VCIT
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in VCIT
MKTLIQ 0.58%
Amazon.com Inc 0.29%
Space Exploration Technologies Corp 0.28%
Meta Platforms Inc 0.27%
Boeing Co 0.27%
Bank of America Corp 0.27%
Pfizer Investment Enterprises Pte Ltd 0.26%
Anheuser-Busch Cos LLC / Anheuser-Busch InBev Worldwide Inc 0.26%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF VCIT Vanguard Intermediate-Term Corporate Bond ETF
Where it sits Thematic ETF Bond ETF
What it is Biotech Tracks an index of Intermediate-Term Corporate Bond
Total return, 1 year +37.5% −1.8%
Its benchmark over the same days not measured −1.8% (SCHI)
Gap to its benchmark not measured 0.0 pts vs SCHI
Expense ratio 0.44% 0.03%
Holdings 245 2340
Net assets, IBB as of Oct 27, 2026 and VCIT as of Sep 30, 2026 $11.0bn $66.6bn

IBB and VCIT on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

VCIT

VCIT tracks an index of Intermediate-Term Corporate Bond. Over the year to Oct 28, 2026 it returned −1.8% with distributions reinvested, against −1.8% for its benchmark, the Bloomberg U.S. 5-10 Year Corporate Bond Index. The prospectus expense ratio is 0.03% a year. It sat 3.2% below its high of Feb 27, 2026 on Oct 28, 2026.

Questions people ask

Are IBB and VCIT in the same category?
IBB is a thematic ETF and VCIT is a bond ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or VCIT?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and VCIT −1.8%.
Which is cheaper, IBB or VCIT?
VCIT is cheaper, by 0.41 percentage points a year. That is about $41 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against VCIT, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-vcit

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.